166 related articles for article (PubMed ID: 34080651)
1. Downregulation of miR‑483‑5p inhibits TGF‑β1‑induced EMT by targeting RhoGDI1 in pulmonary fibrosis.
Huang G; Zhang J; Qing G; Liu D; Wang X; Chen Y; Wu Y; Li Y; Guo S
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34080651
[TBL] [Abstract][Full Text] [Related]
2. miR‑106b‑5p targeting SIX1 inhibits TGF‑β1‑induced pulmonary fibrosis and epithelial‑mesenchymal transition in asthma through regulation of E2F1.
Liu S; Chen X; Zhang S; Wang X; Du X; Chen J; Zhou G
Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33495833
[TBL] [Abstract][Full Text] [Related]
3. Diallyl disulfide inhibits TGF‑β1‑induced upregulation of Rac1 and β‑catenin in epithelial‑mesenchymal transition and tumor growth of gastric cancer.
Su B; Su J; Zeng Y; Ding E; Liu F; Tan T; Xia H; Wu YH; Zeng X; Ling H; Jiang H; Ai XH; Su Q
Oncol Rep; 2018 Jun; 39(6):2797-2806. PubMed ID: 29620286
[TBL] [Abstract][Full Text] [Related]
4. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
[TBL] [Abstract][Full Text] [Related]
5. TGF‑β1 induces CREB1‑mediated miR‑1290 upregulation to antagonize lung fibrosis via Napsin A.
Guan S; Wu Y; Zhang Q; Zhou J
Int J Mol Med; 2020 Jul; 46(1):141-148. PubMed ID: 32319530
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of microRNA‑423‑5p suppresses TGF‑β1‑induced EMT by targeting FOXP4 in airway fibrosis.
Chen Y; Li X; Li Y; Wu Y; Huang G; Wang X; Guo S
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35642665
[TBL] [Abstract][Full Text] [Related]
7. miR‑320a‑3P alleviates the epithelial‑mesenchymal transition of A549 cells by activation of STAT3/SMAD3 signaling in a pulmonary fibrosis model.
Wang X; Wang J; Huang G; Li Y; Guo S
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760151
[TBL] [Abstract][Full Text] [Related]
8. Silibinin attenuates TGF‑β1‑induced migration and invasion via EMT suppression and is associated with COX‑2 downregulation in bladder transitional cell carcinoma.
Li F; Sun Y; Jia J; Yang C; Tang X; Jin B; Wang K; Guo P; Ma Z; Chen Y; Wang X; Chang L; He D; Zeng J
Oncol Rep; 2018 Dec; 40(6):3543-3550. PubMed ID: 30272315
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑101 inhibits renal tubular epithelial‑to‑mesenchymal transition by targeting TGF‑β1 type I receptor.
Wang Q; Tao Y; Xie H; Liu C; Liu P
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33955520
[TBL] [Abstract][Full Text] [Related]
10. Buyang Huanwu Tang inhibits cellular epithelial-to-mesenchymal transition by inhibiting TGF-β1 activation of PI3K/Akt signaling pathway in pulmonary fibrosis model in vitro.
Yin ZF; Wei YL; Wang X; Wang LN; Li X
BMC Complement Med Ther; 2020 Jan; 20(1):13. PubMed ID: 32020862
[TBL] [Abstract][Full Text] [Related]
11. miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM.
Song Q; Xu Y; Yang C; Chen Z; Jia C; Chen J; Zhang Y; Lai P; Fan X; Zhou X; Lin J; Li M; Ma W; Luo S; Bai X
Cancer Res; 2014 Jun; 74(11):3031-42. PubMed ID: 24710410
[TBL] [Abstract][Full Text] [Related]
12. Astragalus polysaccharides attenuate pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition and NF-κB pathway activation.
Zhang R; Xu L; An X; Sui X; Lin S
Int J Mol Med; 2020 Jul; 46(1):331-339. PubMed ID: 32319542
[TBL] [Abstract][Full Text] [Related]
13. miR‑152 regulates TGF‑β1‑induced epithelial‑mesenchymal transition by targeting HPIP in tubular epithelial cells.
Ning YX; Wang XY; Wang JQ; Zeng R; Wang GQ
Mol Med Rep; 2018 Jun; 17(6):7973-7979. PubMed ID: 29620271
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
15. Expression of TRB3 promotes epithelial‑mesenchymal transition of MLE‑12 murine alveolar type II epithelial cells through the TGF‑β1/Smad3 signaling pathway.
Cheng W; Mi L; Tang J; Yu W
Mol Med Rep; 2019 Apr; 19(4):2869-2875. PubMed ID: 30720074
[TBL] [Abstract][Full Text] [Related]
16. Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells.
Yoshida J; Ishikawa T; Endo Y; Matsumura S; Ota T; Mizushima K; Hirai Y; Oka K; Okayama T; Sakamoto N; Inoue K; Kamada K; Uchiyama K; Takagi T; Naito Y; Itoh Y
Oncol Rep; 2020 Jul; 44(1):371-381. PubMed ID: 32627027
[TBL] [Abstract][Full Text] [Related]
17. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
18. Febuxostat inhibits TGF‑β1‑induced epithelial‑mesenchymal transition via downregulation of USAG‑1 expression in Madin‑Darby canine kidney cells in vitro.
Lu L; Zhu J; Zhang Y; Wang Y; Zhang S; Xia A
Mol Med Rep; 2019 Mar; 19(3):1694-1704. PubMed ID: 30628645
[TBL] [Abstract][Full Text] [Related]
19. S1PR3 deficiency alleviates radiation-induced pulmonary fibrosis through the regulation of epithelial-mesenchymal transition by targeting miR-495-3p.
Gong L; Wu X; Li X; Ni X; Gu W; Wang X; Ji H; Hu L; Zhu L
J Cell Physiol; 2020 Mar; 235(3):2310-2324. PubMed ID: 31489649
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis.
Zhang Z; Qu J; Zheng C; Zhang P; Zhou W; Cui W; Mo X; Li L; Xu L; Gao J
Cell Death Dis; 2018 Jan; 9(2):83. PubMed ID: 29362432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
